Page last updated: 2024-10-30

lauric acid and Parkinson Disease

lauric acid has been researched along with Parkinson Disease in 1 studies

dodecanoic acid : A straight-chain, twelve-carbon medium-chain saturated fatty acid with strong bactericidal properties; the main fatty acid in coconut oil and palm kernel oil.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zaidi, AA1
Khan, MA1
Shahreyar, ZA1
Ahmed, H1

Other Studies

1 other study available for lauric acid and Parkinson Disease

ArticleYear
Lauric acid: Its role in behavioral modulation, neuro-inflammatory and oxidative stress markers in haloperidol induced Parkinson's disease.
    Pakistan journal of pharmaceutical sciences, 2020, Volume: 33, Issue:2(Suppleme

    Topics: Animals; Antioxidants; Biomarkers; Corpus Striatum; Cytokines; Haloperidol; Inflammation; Lauric Aci

2020